Call Us Now
 
Facebook-f Instagram Linkedin-in
CONTACT US
LOGIN

Travoprost Eye Drops in Kolkata: A Specialized Ophthalmic Solution for Glaucoma Care

Travoprost Eye Drops for Kolkata's Ophthalmic Market

Kolkata has a broad healthcare network that includes hospitals, specialist clinics, pharmacies, ophthalmologists and pharmaceutical distribution channels. Within this environment, specialized ophthalmic products from EyeKare Kilitch require appropriate formulations, controlled manufacturing and dependable supply. Anti-glaucoma medicines form an important category within ophthalmology, with different active ingredients and dosage forms selected according to professional assessment and individual treatment requirements. 

EyeKare Kilitch lists OPTRVO as Travoprost Eye Drops IP 0.004% w/v BAK FREE Sterile Ophthalmic Solution. The company’s product portfolio also includes TRAVOPROSTIN, listed as Travoprost Preservative Free Eye Drops with Travoprost IP 0.004% w/v. For organizations researching Travoprost Eye Drops in Kolkata, these products provide clearly identified Travoprost formulations within EyeKare’s ophthalmology-focused portfolio.

Understanding Travoprost Ophthalmic Solutions

Travoprost is an ophthalmic medicine used in glaucoma care to help lower elevated intraocular pressure. It belongs to the prostaglandin analogue category and is used under appropriate medical supervision. The exact choice of glaucoma medicine depends on the patient’s condition, clinical history, response to treatment and the prescribing ophthalmologist’s assessment. 

EyeKare’s official product information identifies OPTRVO as a sterile ophthalmic solution containing Travoprost IP 0.004% w/v and specifically describes it as BAK free. The portfolio separately identifies TRAVOPROSTIN as a preservative-free Travoprost eye drop at the same stated strength. These distinctions are useful for businesses reviewing product specifications and packaging technologies.

OPTRVO: BAK-Free Travoprost Eye Drops

OPTRVO is one of EyeKare Kilitch’s listed anti-glaucoma products. Its product description specifies Travoprost Eye Drops IP 0.004% w/v and identifies the dosage form as a BAK-free sterile ophthalmic solution. This provides a defined product profile for distributors, pharmacies and healthcare organizations evaluating Travoprost formulations. 

When reviewing an ophthalmic product, businesses should consider the active ingredient, concentration, dosage form, preservative or preservative-free positioning, packaging, regulatory documentation and supply requirements. These details help procurement teams compare products accurately rather than relying only on the generic term eye drops. 

TRAVOPROSTIN: Preservative-Free Travoprost

EyeKare’s portfolio also lists TRAVOPROSTIN as Travoprost Preservative Free Eye Drops, with Travoprost IP 0.004% w/v and Water for Injections IP q.s. This product provides another clearly identified Travoprost option within the company’s ophthalmic range. 

The availability of both BAK-free and preservative-free Travoprost products gives businesses specific formulation attributes to evaluate. The appropriate product should always be selected using approved product information, professional prescribing requirements and the needs of the intended healthcare channel. 

Why Formulation and Packaging Matter

Ophthalmic medicines are applied directly to the eye, making formulation quality and packaging important considerations. EyeKare highlights preservative-free technology as a major area of its innovation program. The company states that its Novelia technology is a multi-dose closing-tip system designed to avoid preservatives while preventing bacterial contamination during treatment.  

Packaging technology can be evaluated alongside formulation and sterility. Delivery systems, storage requirements and administration instructions should be reviewed using the relevant product documentation. 

Manufacturing and Quality Considerations

EyeKare Kilitch describes itself as a specialized ophthalmic division of Kilitch Healthcare India Ltd. Its website states that its products are manufactured in-house in a facility spread across 3,50,000 square feet and compliant with international standards. The company also highlights more than 50 scientists working across research and development and quality control. 

For pharmaceutical businesses evaluating a Travoprost supplier, manufacturing infrastructure, quality-control processes, formulation capabilities, documentation and supply reliability are important areas to assess. These factors are especially relevant for sterile ophthalmic products intended for regulated healthcare channels. 

Travoprost in Glaucoma Care

Glaucoma management aims to control factors that can contribute to optic nerve damage, and treatment is individualized. Travoprost may be prescribed as part of an ophthalmologist-directed treatment plan. Patients and healthcare businesses should not treat a product description as a substitute for medical advice or approved prescribing information. 

Understanding the therapeutic category helps with portfolio planning. EyeKare’s product range places Travoprost alongside other anti-glaucoma formulations, including Travoprost and Timolol combinations, Dorzolamide, Dorzolamide and Timolol, Timolol, and Brinzolamide and Brimonidine combinations.

What to Consider When Selecting Travoprost Eye Drops

Confirm the Strength 

EyeKare lists OPTRVO with Travoprost IP 0.004% w/v. Confirming the exact strength and composition against the approved product information is essential when evaluating procurement requirements. 

Review the Formulation 

OPTRVO is identified as a BAK-free sterile ophthalmic solution, while TRAVOPROSTIN is listed as a preservative-free eye drop. Businesses should distinguish these product descriptions and evaluate the formulation that matches the intended requirement. 

Assess the Manufacturer 

A specialist ophthalmic manufacturer should be reviewed through its manufacturing capabilities, quality systems, product documentation, packaging technology and ability to support consistent supply. This broader assessment can provide a stronger basis for supplier selection. 

EyeKare's Ophthalmology-Focused Product Portfolio

EyeKare states that it is deeply committed to ophthalmology and offers a comprehensive range of ophthalmic solutions covering multiple therapeutic areas. Its current product portfolio includes anti-glaucoma, lubricants, anti-allergic, antibiotic, NSAID and other ophthalmic categories.  

Businesses can review the EyeKare ophthalmic product portfolio to compare OPTRVO and TRAVOPROSTIN with other glaucoma formulations. This can help procurement teams understand the wider range available from a specialist ophthalmic supplier. 

Supporting Ophthalmic Procurement in Kolkata

EyeKare’s ophthalmology specialization and product range provide businesses with a focused platform for evaluating eye-care formulations. Its Travoprost offerings can be considered alongside other anti-glaucoma products when organizations are planning a broader ophthalmic portfolio. 

Why Consider EyeKare Kilitch for Travoprost?

EyeKare Kilitch offers clearly identified Travoprost products, including OPTRVO as a BAK-free sterile ophthalmic solution and TRAVOPROSTIN as a preservative-free eye drop. The company’s stated in-house manufacturing and ophthalmology-focused approach provide additional factors for businesses to consider when evaluating a specialized supplier. 

For organizations evaluating OPTRVO Travoprost eye drops, the 0.004% w/v strength, BAK-free positioning and sterile ophthalmic solution format provide specific product attributes to review. The final selection should be based on approved product information, professional requirements and applicable regulations. 

Conclusion

Travoprost is an important option within the anti-glaucoma ophthalmic category. EyeKare’s current portfolio lists OPTRVO as Travoprost Eye Drops IP 0.004% w/v BAK FREE Sterile Ophthalmic Solution and TRAVOPROSTIN as Travoprost Preservative Free Eye Drops. 

For businesses searching for Travoprost Eye Drops in Kolkata, EyeKare Kilitch offers specialized Travoprost formulations within its ophthalmology-focused portfolio. Its stated manufacturing infrastructure, product range and focus on ophthalmic innovation provide relevant factors for supplier evaluation. 

Subscribe Our News Letter!

Subscribe to the EyeCare newsletter to receive updates on the latest developments, events and innovations in ophthalmology.

EyeKare Kilitch  is an innovative pharmaceutical company that discovers, develop, manufactures and market a broad range of healthcare products.

Facebook-f Instagram

Useful links

Contact Us

+91-22-6137 2222

info@eyekare.in

902-B, Godrej Coliseum, Behind Everard Nagar, Off. Eastern Express Highway, Nr. Priyadarshani Circle, Sion (E.), Mumbai - 400 022. INDIA.

© Copyright 2024 – EyeKareKilitch

Group of Companies